Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fatty Liver × Metformin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 14 Colorectal Neoplasms 12 Rectal Neoplasms 4 Adenocarcinoma 4 Colonic Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Barrett Esophagus 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Obesity 1 Non-DM Stage II High-risk Colorectal Cancer 1 Neoplasms 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Fatty Liver 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Diabetes Mellitus, Type 2 1

Interventions

atezolizumab 1 Tomography, X-Ray Computed 1 Metformin 1 Liquid Biopsy 1 Endosonography 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01523639 2018-12-19

G-LUCAS

Austrian Breast & Colorectal Cancer Study Group

Phase 2 Terminated

Gastrointestinal

Fatty Liver, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡